TRNS - Transcat, Inc. Stock Analysis | Stock Taper
Logo
Transcat, Inc.

TRNS

Transcat, Inc. NASDAQ
$92.23 0.38% (+0.35)

Market Cap $861.49 M
52w High $94.76
52w Low $50.23
P/E 60.68
Volume 294.67K
Outstanding Shares 9.34M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $89.33M $27.25M $1.95M 2.18% $0.21 $11.26M
Q3-2025 $83.86M $25.16M $-1.1M -1.31% $-0.12 $7.19M
Q2-2025 $82.27M $23.26M $1.27M 1.54% $0.14 $9.79M
Q1-2025 $77.13M $18.97M $4.46M 5.79% $0.48 $12.35M
Q4-2024 $77.13M $18.97M $4.46M 5.79% $0.49 $12.35M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $4.94M $480.49M $179.87M $300.62M
Q3-2025 $3.47M $472.89M $176.12M $296.77M
Q2-2025 $5.08M $484.89M $189.47M $295.42M
Q1-2025 $1.86M $392.54M $100M $292.54M
Q4-2024 $1.52M $385.24M $98.36M $286.88M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $1.95M $6.17M $-3.59M $-488K $1.47M $2.59M
Q3-2025 $-1.1M $12.17M $-2.68M $-12.21M $-1.61M $9.49M
Q2-2025 $1.27M $12.86M $-86.96M $77.25M $3.22M $8.42M
Q1-2025 $3.26M $3.62M $-4.6M $1.95M $344K $-975K
Q4-2024 $4.46M $10.63M $-4.04M $-9.45M $-3.12M $7.93M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Distribution Service
Distribution Service
$30.00M $30.00M $30.00M $30.00M
Service
Service
$50.00M $50.00M $50.00M $60.00M

Revenue by Geography

Region Q1-2025Q2-2025Q3-2025Q4-2025
CANADA
CANADA
$0 $0 $0 $0
UNITED STATES
UNITED STATES
$70.00M $80.00M $80.00M $80.00M

Q4 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Transcat, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key strengths include solid profitability supported by strong gross margins, robust operating and free cash flow, and a very healthy liquidity position. The balance sheet carries moderate leverage and a sizable equity cushion, providing flexibility to pursue growth initiatives. Competitively, Transcat benefits from deep specialization in regulated industries, a wide accredited lab network, proprietary software platforms, and an integrated model that spans distribution, rentals, services, and consulting. These features create sticky customer relationships and position the company as a strategic partner rather than a simple supplier.

! Risks

The main risks stem from thin operating and net margins, heavy use of acquisitions, and a balance sheet concentrated in goodwill and other intangibles. An acquisition‑driven strategy can strain integration capacity and heighten the risk of asset write‑downs if deals underperform. Reliance on external financing to fund large investments adds sensitivity to credit conditions and interest costs. Competitive pressures, potential regulatory changes, or slower adoption of the company’s technology initiatives could also weigh on pricing power and returns. Finally, the lack of explicit R&D reporting makes it harder to assess the full level of organic innovation spending.

Outlook

Overall, the outlook appears cautiously constructive. The business generates solid cash from operations, has room on the balance sheet to invest, and operates in end markets where compliance, precision, and uptime should support steady demand. Its strategic focus on technology, AI‑enabled services, and expansion into high‑growth, high‑specification sectors offers meaningful opportunity, provided execution remains disciplined. At the same time, thin margins, acquisition intensity, and intangible‑heavy assets introduce vulnerabilities that warrant ongoing monitoring. Future performance will depend largely on the company’s ability to integrate acquisitions, scale its software and automation platforms, and maintain its standing as a trusted partner in regulated industries.